Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

138 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-10

Study Completion Date

2025-02-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intimate violence against individuals, which is particularly marked among women, is one of the most widespread human rights violations in the world.

The Women Abuse Screening Tool (WAST) self-questionnaire is a screening tool validated in French.

Our preliminary data describing the association between intimate violence against women and the first attack of unexplained venous thromboembolic disease, show a significant frequency of positive responses to the WAST among women attending a biological hematology consultation at the CHU de Nîmes, for reasons of hemostasis disorders (8% out of the first 200 cases).

The study authors wish to establish the prevalence of this situation among patients presenting to the CHU de Nîmes for hematological exploration and management. They hypothesize that the prevalence of violence against individuals seen in Hematology consultations is higher among individuals with hemostasis pathologies (hemorrhagic and thrombotic pathologies) than those with cellular pathologies, and higher among women than men.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women

NCT05890924

Venous Thrombosis

COMPLETED

Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic Episode

NCT04920487

Venous Thromboembolism

COMPLETED

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure

NCT03206372

Venous Thromboembolic Disease

RECRUITING

Incidence and Risk Factors of Venous Thrombosis of the Lower Limbs After Hospitalization in Medical Patients at Risk

NCT05512923

Patients Hospitalized for More Than 48 Hours Acute Medical Illness

RECRUITING

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the PREFER-PostPartum

NCT05318547

Pregnancy

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intimate Partner Violence Deep Vein Thrombosis (DVT)/Thrombophlebitis Pulmonary Embolism and Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients presenting at a biological hematology consultation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently in a relationship or has been in one in the last 12 months, regardless of the length of the relationship
* Willing to complete the anonymous WAST self-questionnaire
* able to read and understand French
* Outpatient consultant at Nîmes University Hospital in one of the following departments:

* Biological hematology consultation
* Clinical hematology consultation
* Vascular medicine consultation

Exclusion Criteria

* Individuals under court protection, guardianship or curatorship
* Individuals unable to read and understand French
* Individuals who have already completed the WAST questionnaire during the study period
* Individuals unable to get away from their partner during the consultation to complete the questionnaire in isolation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No